Cargando…
Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
Autores principales: | Belbin, Olivia, Lehmann, Sylvain, Sabidó, Eduard, Hirtz, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726015/ https://www.ncbi.nlm.nih.gov/pubmed/33324192 http://dx.doi.org/10.3389/fnagi.2020.00232 |
Ejemplares similares
-
Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top–Down Proteomics: A Pilot Study
por: Molinari, Nicolas, et al.
Publicado: (2018) -
Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson’s Disease
por: Pons, Marie-Laure, et al.
Publicado: (2022) -
The alternative proteome in neurobiology
por: Mohaupt, Pablo, et al.
Publicado: (2022) -
Editorial: Molecular biomarkers in the prediction, diagnosis, and prognosis of neurodegenerative diseases
por: Xu, Yuzhen, et al.
Publicado: (2023) -
The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
por: Davidsson, Pia, et al.
Publicado: (2005)